$61.17 -0.31 (-0.50%) Merck & Co Inc - New York Stock Exchange, Inc.

Jan. 18, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 61.17
Trade Time: Jan 18 04:00 PM Eastern Daylight Time
Change: -0.31 (-0.50%)
Prev Close: 61.48
Open: 61.38
Bid: 61.10
Ask: 61.26
  1. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily | Jan. 17, 2017 | 14:21PM EST
  2. Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy

    TalkMarkets | Jan. 14, 2017 | 12:58PM EST
  3. Week In Review: China's Sanpower Pays $820M For Provenge, A Prostate Immunotherapy

    TalkMarkets | Jan. 14, 2017 | 12:58PM EST
  4. Merck Carries Incyte On Keytruda Coattails In 4 'Hot' Tumors: Leerink

    Investors Business Daily | Jan. 13, 2017 | 12:52PM EST
  5. Stocks Get Defensive; Fiat Slumps, But Amazon A Bright Spot In Tech

    Investors Business Daily | Jan. 12, 2017 | 14:59PM EST
  6. Analysts See Merck Rally Continuing After Lung Cancer Drug News

    TalkMarkets | Jan. 12, 2017 | 14:31PM EST
  7. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily | Jan. 12, 2017 | 14:00PM EST
  8. Stocks Stuck In Red; Apple, Disney Weigh On Dow; Nvidia Extends Slide

    Investors Business Daily | Jan. 12, 2017 | 13:46PM EST
  9. Bristol-Myers Threatens Merck's 'Head Start' In Lung Cancer: Analyst

    Investors Business Daily | Jan. 12, 2017 | 11:14AM EST
  10. Markets Sound The Retreat In Early Trading; Merck 'New Best Idea'

    Investors Business Daily | Jan. 12, 2017 | 10:12AM EST
  11. Stock Futures Slip, Dollar Slides As Market Awaits Fed Comments

    Investors Business Daily | Jan. 12, 2017 | 08:01AM EST
  12. Trump Talks; Biotechs, Lockheed Fall; Merck Buoys Dow, Microchip Up

    Investors Business Daily | Jan. 11, 2017 | 15:00PM EST
  13. Trump Shoots Down Biotechs, Lockheed; Apple, Nvidia Weigh On Nasdaq

    Investors Business Daily | Jan. 11, 2017 | 13:41PM EST
  14. Merck Lung-Cancer Drug May Get OK For Large Patient Population

    Investors Business Daily | Jan. 11, 2017 | 12:28PM EST
  15. Bristol-Myers slips after FDA gives Merck lung cancer therapy priority review

    TalkMarkets | Jan. 11, 2017 | 11:50AM EST
Trading Center